Drug
daunorubicin
1 HCP commentary report on clinical trials studying daunorubicin. Each report covers what clinicians said in public about one trial, with the source behind every view.
| Trial | Indication | Phase | Statements | HCP sources | Size | Updated | Preview |
|---|---|---|---|---|---|---|---|
| KO-MEN-017 NCT07007312 · Kura Oncology, Inc. | Not given | Phase 3 | 34 | 7 | Focused | Oct 19, 2026 | Preview |